Henrieta Grešlíková
- Co-authors
- Roman HájekPetr KuglíkLuděk PourMarta KrejčíViera SandeckáZdeněk AdamFedor KryukovJiří Jarkovský
- Topics
- Multiple Myeloma Research and Treatments (12 papers)Protein Degradation and Inhibitors (3 papers)Chromosomal and Genetic Variations (2 papers)
- Cited by
- HematologyCancer ResearchOncology
- Partner nations
- CzechiaUgandaSouth Korea
In The Last Decade
Henrieta Grešlíková
13 papers receiving 371 citations
Peers
Comparison fields: 5 of 37
- Hematology 301
- Molecular Biology 277
- Oncology 150
- Cancer Research 84
- Genetics 50
Countries citing papers authored by Henrieta Grešlíková
This map shows the geographic impact of Henrieta Grešlíková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrieta Grešlíková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrieta Grešlíková more than expected).
Fields of papers citing papers by Henrieta Grešlíková
This network shows the impact of papers produced by Henrieta Grešlíková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrieta Grešlíková. The network helps show where Henrieta Grešlíková may publish in the future.
Co-authorship network of co-authors of Henrieta Grešlíková
This figure shows the co-authorship network connecting the top 25 collaborators of Henrieta Grešlíková. A scholar is included among the top collaborators of Henrieta Grešlíková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henrieta Grešlíková. Henrieta Grešlíková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 41 | |
| 2 | 24 | |
| 3 | 1 | |
| 4 | 93 | |
| 5 | 124 | |
| 6 | 13 | |
| 7 | Altered gene expression in multiple myeloma patients with gainof 1q21 locus. | 1 |
| 8 | 15 | |
| 9 | 8 | |
| 10 | 54 | |
| 11 | 1 | |
| 12 | Comparison of prognostic impact of chromosome 1q21 gain inpatients with multiple myeloma treated by Velcade, thalidomideand any conventional therapy | 1 |
| 13 | 1 |
About Henrieta Grešlíková
Henrieta Grešlíková is a scholar working on Hematology, Immunology and Allergy and Cell Biology, having authored 13 papers that have together received 377 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (12 papers), Protein Degradation and Inhibitors (3 papers) and Chromosomal and Genetic Variations (2 papers). The work is most often cited by research in Hematology (301 citations), Cancer Research (84 citations) and Oncology (150 citations). Henrieta Grešlíková has collaborated with scholars based in Czechia, Uganda and South Korea. Frequent co-authors include Roman Hájek, Petr Kuglík, Luděk Pour, Marta Krejčí, Viera Sandecká, Zdeněk Adam, Zdeněk Adam, Fedor Kryukov, Jiří Jarkovský and Jan Smetana. Their work appears in journals such as Blood, British Journal of Haematology and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.